Cysteamine en es it fr

Cysteamine Brand names, Cysteamine Analogs

Cysteamine Brand Names Mixture

  • No information avaliable

Cysteamine Chemical_Formula

C2H7NS

Cysteamine RX_link

No information avaliable

Cysteamine fda sheet

Cysteamine msds (material safety sheet)

Cysteamine Synthesis Reference

No information avaliable

Cysteamine Molecular Weight

77.1497 g/mol

Cysteamine Melting Point

98 oC

Cysteamine H2O Solubility

No information avaliable

Cysteamine State

Solid

Cysteamine LogP

-0.196

Cysteamine Dosage Forms

Capsule (50 mg, 150 mg)

Cysteamine Indication

Given intravenously or orally to treat radiation sickness. The bitartrate has been used for the oral treatment of nephropathic cystinosis.

Cysteamine Pharmacology

People born without the ability to metabolize the amino acid cystine suffer from cystinosis, a rare inherited disorder characterized by the deposition and accumulation of cystine crystals throughout the body. These crystals cause considerable damage, particularly in the kidney. Kidney failure can occur by the age of 10 in untreated patients. Cysteamine prevents the accumulation of cystine crystals and is prescribed to prevent further kidney damage. Cysteamine helps to convert cystine into less harmful chemical forms that can be removed from cells.

Cysteamine Absorption

No information avaliable

Cysteamine side effects and Toxicity

Symptoms of overdose may include convulsions (seizures), increased thirst and unusual tiredness or weakness.

Cysteamine Patient Information

No information avaliable

Cysteamine Organisms Affected

Humans and other mammals